PL1680405T3 - Pochodne bengamidu i ich zastosowanie do leczenia chorób nowotworowych - Google Patents

Pochodne bengamidu i ich zastosowanie do leczenia chorób nowotworowych

Info

Publication number
PL1680405T3
PL1680405T3 PL04765884T PL04765884T PL1680405T3 PL 1680405 T3 PL1680405 T3 PL 1680405T3 PL 04765884 T PL04765884 T PL 04765884T PL 04765884 T PL04765884 T PL 04765884T PL 1680405 T3 PL1680405 T3 PL 1680405T3
Authority
PL
Poland
Prior art keywords
cancer
treatment
bengamide derivatives
bengamide
derivatives
Prior art date
Application number
PL04765884T
Other languages
English (en)
Inventor
Holger Hoffmann
Sabine Haag-Richter
Michael Kurz
Heiko Tietgen
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PL1680405T3 publication Critical patent/PL1680405T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL04765884T 2003-10-24 2004-10-08 Pochodne bengamidu i ich zastosowanie do leczenia chorób nowotworowych PL1680405T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10349669A DE10349669B3 (de) 2003-10-24 2003-10-24 Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP2004/011244 WO2005044803A1 (de) 2003-10-24 2004-10-08 Bengamide-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krebserkrankungen
EP04765884A EP1680405B1 (de) 2003-10-24 2004-10-08 Bengamide-derivate und deren verwendung zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
PL1680405T3 true PL1680405T3 (pl) 2009-06-30

Family

ID=34484998

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04765884T PL1680405T3 (pl) 2003-10-24 2004-10-08 Pochodne bengamidu i ich zastosowanie do leczenia chorób nowotworowych

Country Status (30)

Country Link
EP (2) EP1873146B1 (pl)
JP (1) JP4769190B2 (pl)
KR (1) KR20060120044A (pl)
CN (2) CN101294173A (pl)
AR (1) AR046553A1 (pl)
AT (2) ATE420074T1 (pl)
AU (1) AU2004287561B2 (pl)
BR (1) BRPI0415529A (pl)
CA (1) CA2543003A1 (pl)
CL (1) CL2009000674A1 (pl)
CY (1) CY1110458T1 (pl)
DE (3) DE10349669B3 (pl)
DK (1) DK1680405T3 (pl)
ES (1) ES2320894T3 (pl)
HK (1) HK1098131A1 (pl)
HR (1) HRP20090187T1 (pl)
IL (1) IL174524A (pl)
MA (1) MA28213A1 (pl)
ME (1) MEP33108A (pl)
MX (1) MXPA06004084A (pl)
NO (1) NO20062149L (pl)
NZ (1) NZ546744A (pl)
PL (1) PL1680405T3 (pl)
PT (1) PT1680405E (pl)
RS (1) RS20060263A (pl)
RU (1) RU2357956C2 (pl)
SI (1) SI1680405T1 (pl)
UY (1) UY28574A1 (pl)
WO (1) WO2005044803A1 (pl)
ZA (1) ZA200602231B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
CN1191237C (zh) * 2000-05-11 2005-03-02 诺瓦提斯公司 取代的己内酰胺碳酸酯与醚和它们作为抗肿瘤剂的用途
JP2004262793A (ja) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
JP2006528611A (ja) * 2003-07-25 2006-12-21 ノバルティス アクチエンゲゼルシャフト 置換ラクタムおよびそれらの抗がん剤としての使用

Also Published As

Publication number Publication date
IL174524A (en) 2012-08-30
RU2006117769A (ru) 2007-11-27
HRP20090187T1 (en) 2009-05-31
CL2009000674A1 (es) 2009-08-07
ZA200602231B (en) 2007-06-27
DK1680405T3 (da) 2009-05-04
EP1873146B1 (de) 2010-08-11
EP1873146A2 (de) 2008-01-02
CA2543003A1 (en) 2005-05-19
AU2004287561B2 (en) 2011-06-02
JP4769190B2 (ja) 2011-09-07
SI1680405T1 (sl) 2009-06-30
DE502004011536D1 (de) 2010-09-23
ATE420074T1 (de) 2009-01-15
MEP33108A (en) 2010-10-10
CN101294173A (zh) 2008-10-29
ATE477244T1 (de) 2010-08-15
AR046553A1 (es) 2005-12-14
ES2320894T3 (es) 2009-05-29
RS20060263A (en) 2008-09-29
DE10349669B3 (de) 2005-05-25
DE502004008837D1 (de) 2009-02-26
WO2005044803A1 (de) 2005-05-19
MA28213A1 (fr) 2006-10-02
EP1873146A3 (de) 2008-05-21
IL174524A0 (en) 2006-08-01
BRPI0415529A (pt) 2006-12-26
KR20060120044A (ko) 2006-11-24
NZ546744A (en) 2009-03-31
HK1098131A1 (en) 2007-07-13
UY28574A1 (es) 2005-05-31
EP1680405A1 (de) 2006-07-19
PT1680405E (pt) 2009-03-31
MXPA06004084A (es) 2006-06-27
JP2007509084A (ja) 2007-04-12
EP1680405B1 (de) 2009-01-07
NO20062149L (no) 2006-07-11
CY1110458T1 (el) 2015-04-29
CN1871217A (zh) 2006-11-29
AU2004287561A1 (en) 2005-05-19
RU2357956C2 (ru) 2009-06-10
CN100398520C (zh) 2008-07-02

Similar Documents

Publication Publication Date Title
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
PL370029A1 (pl) Pochodne 2-amino-4-heteroaryloaminopirymidyny do stosowania w leczeniu raka
ZA200500618B (en) Combinations of drugs for the treatment of neoplasms
IL157425A0 (en) Treatment of solid tumours with paramycin derivatives
PL375532A1 (pl) Związki benzimidazol-1-ilotiofenowe do leczenia nowotworów
EP1613308A4 (en) CANCER TREATMENT METHODS
IL206984A0 (en) Analoges of benzoquinone-containing ansamycins for the treatment of cancer
HK1086573A1 (en) Quinazoline derivatives for treatment of cancer
HK1068551A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
PL373912A1 (pl) Heterocykliczne pochodne do leczenia raka i innych chorób proliferacyjnych
AU2003212634A8 (en) Compounds useful in the treatment of cancer
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
AU2003251904A8 (en) Combinations of drugs for the treatment of neoplasms
GB0213869D0 (en) The treatment of pain
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
PL375564A1 (pl) Podstawione 5-chroman-5-ylo-etyloaminy i ich zastosowanie do leczenia jaskry
HK1098131A1 (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
AU2003231803A8 (en) Treatment of cancer with mefloquire
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
EP1684795A4 (en) METHODS AND AGENTS FOR THE TREATMENT OF CANCER
GB0329416D0 (en) Treatment of cancer
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003905726A0 (en) Methods and agents for the treatment of cancer